Lot numbers can be found on the outside label of a product:
1,4-bis((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)butane-1,4-dione Tofacitinib Impurity
-
CAS No. None
- Cat. No. CS-0164250
- Purity≥98%
- MDL No.None
*For research and further manufacturing use only, not for direct human use.
![1,4-bis((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)butane-1,4-dione Tofacitinib Impurity|CS-0164250](https://file.chemscene.com/productPIC/CS-0164250.gif)
Please choose your location and provide accurate information for you
| Size |
|
Price | Quantity | |||
|---|---|---|---|---|---|---|
|
* Please select Quantity before adding items. |
||||||
Recommended Products
General Information
- CAS No. None
- Cat. No. CS-0164250
- Purity ≥98%
- MDL No. None
- Storage Sealed in dry,2-8℃
- Shipping Room temperature in continental US; may vary elsewhere.
- Molecular Formula C₃₀H₄₀N₁₀O₂
- Molecular Weight 572.70
- Synonym(s) None
- SMILES O=C(N1C[C@H](N(C)C2=C3C(NC=C3)=NC=N2)[C@H](C)CC1)CCC(N4C[C@H](N(C)C5=C6C(NC=C6)=NC=N5)[C@H](C)CC4)=O
Safety Information
Download SDS|
GHS Pictogram :
|
GHS No : GHS07
|
|
Signal Word : Warning
|
UN#: N/A
|
|
Class : N/A
|
Packing Group : N/A
|
|
Hazard Statements : H302-H315-H319-H335
|
|
|
Precautionary Statements : P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
|
|
Quality Control
Computational Chemistry Data
- TPSA 130.24
- LogP 3.056
- H_Acceptors 8
- H_Donors 2
- Rotatable_Bonds 7
Similar Products
Recently Viewed Products
Leave US a Message
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Upload Pictures
|
|
Key Words
- 1,4-bis((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)butane-1,4-dione Tofacitinib Impurity sigma1,4-bis((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)butane-1,4-dione Tofacitinib Impurity manufacturer1,4-bis((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)butane-1,4-dione Tofacitinib Impurity price1,4-bis((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)butane-1,4-dione Tofacitinib Impurity structure1,4-bis((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)butane-1,4-dione Tofacitinib Impurity SDSbuy 1,4-bis((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)butane-1,4-dione Tofacitinib Impurity1,4-bis((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)butane-1,4-dione Tofacitinib Impurity supplier1,4-bis((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)butane-1,4-dione Tofacitinib Impurity uses1,4-bis((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)butane-1,4-dione Tofacitinib Impurity molecular weightprice of 1,4-bis((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)butane-1,4-dione Tofacitinib Impurity1,4-bis((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)butane-1,4-dione Tofacitinib Impurity chemical name formula of 1,4-bis((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)butane-1,4-dione Tofacitinib Impurity